Key statistics
On Friday, Rocket Pharmaceuticals Inc (9IP1:FRA) closed at 18.73, 19.15% above the 52 week low of 15.72 set on Sep 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.73 |
---|---|
High | 18.73 |
Low | 18.73 |
Bid | -- |
Offer | -- |
Previous close | 18.43 |
Average volume | 158.30 |
---|---|
Shares outstanding | 90.98m |
Free float | 86.62m |
P/E (TTM) | -- |
Market cap | 1.83bn USD |
EPS (TTM) | -2.79 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:21 BST.
More ▼
Press releases
- Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
- Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
- Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
- Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
- Rocket Pharmaceuticals Provides Regulatory Update on KRESLADI™ (marnetegragene autotemcel; marne-cel)
More ▼